An Engineered IL15 Cytokine Mutein Fused to an Anti-PD1 Improves Intratumoral T-cell Function and Antitumor Immunity.
Saved in:
| Title: | An Engineered IL15 Cytokine Mutein Fused to an Anti-PD1 Improves Intratumoral T-cell Function and Antitumor Immunity. |
|---|---|
| Authors: | Xu Y; Cancer Immunology Discovery, Pfizer Inc., San Diego, California., Carrascosa LC; Gastroenterology and Hepatology, Erasmus Medical Center, Rotterdam, the Netherlands., Yeung YA; BMD, Pfizer Inc., San Diego, California., Chu ML; BMD, Pfizer Inc., San Diego, California., Yang W; Computational Biology, Pfizer Inc., San Diego, California., Djuretic I; Cancer Immunology Discovery, Pfizer Inc., San Diego, California., Pappas DC; Cancer Immunology Discovery, Pfizer Inc., San Diego, California., Zeytounian J; Cancer Immunology Discovery, Pfizer Inc., San Diego, California., Ge Z; Gastroenterology and Hepatology, Erasmus Medical Center, Rotterdam, the Netherlands., de Ruiter V; Gastroenterology and Hepatology, Erasmus Medical Center, Rotterdam, the Netherlands., Starbeck-Miller GR; Cancer Immunology Discovery, Pfizer Inc., San Diego, California., Patterson J; Cancer Immunology Discovery, Pfizer Inc., San Diego, California., Rigas D; Cancer Immunology Discovery, Pfizer Inc., San Diego, California., Chen SH; Cancer Immunology Discovery, Pfizer Inc., San Diego, California., Kraynov E; BMD, Pfizer Inc., San Diego, California., Boor PP; Gastroenterology and Hepatology, Erasmus Medical Center, Rotterdam, the Netherlands., Noordam L; Gastroenterology and Hepatology, Erasmus Medical Center, Rotterdam, the Netherlands., Doukas M; Pathology, Erasmus Medical Center, Rotterdam, the Netherlands., Tsao D; Cancer Immunology Discovery, Pfizer Inc., San Diego, California., Ijzermans JN; Surgery, Erasmus Medical Center, Rotterdam, the Netherlands., Guo J; BMD, Pfizer Inc., San Diego, California., Grünhagen DJ; Surgery, Erasmus Medical Center, Rotterdam, the Netherlands., Erdmann J; Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., Verheij J; Pathology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., van Royen ME; Pathology, Erasmus Medical Center, Rotterdam, the Netherlands.; Cancer Treatment Screening Facility (CTSF), Erasmus Medical Center, Rotterdam, the Netherlands., Doornebosch PG; Surgery, IJsselland Hospital, Capelle aan den IJssel, the Netherlands., Feldman R; Cancer Immunology Discovery, Pfizer Inc., San Diego, California., Park T; Cancer Immunology Discovery, Pfizer Inc., San Diego, California., Mahmoudi S; Cancer Immunology Discovery, Pfizer Inc., San Diego, California., Dorywalska M; BMD, Pfizer Inc., San Diego, California., Ni I; BMD, Pfizer Inc., San Diego, California., Chin SM; BMD, Pfizer Inc., San Diego, California., Mistry T; BMD, Pfizer Inc., San Diego, California., Mosyak L; BMD, Pfizer Inc., San Diego, California., Lin L; BMD, Pfizer Inc., San Diego, California., Ching KA; Computational Biology, Pfizer Inc., San Diego, California., Lindquist KC; BMD, Pfizer Inc., San Diego, California., Ji C; DSRD, Pfizer Inc., San Diego, California., Londono LM; Cancer Immunology Discovery, Pfizer Inc., San Diego, California., Kuang B; BMD, Pfizer Inc., San Diego, California., Rickert R; Cancer Immunology Discovery, Pfizer Inc., San Diego, California., Kwekkeboom J; Gastroenterology and Hepatology, Erasmus Medical Center, Rotterdam, the Netherlands., Sprengers D; Gastroenterology and Hepatology, Erasmus Medical Center, Rotterdam, the Netherlands. javier.chaparro-riggers@pfizer.com d.sprengers@erasmusmc.nl tzu-hsuan.huang@pfizer.com., Huang TH; Cancer Immunology Discovery, Pfizer Inc., San Diego, California. javier.chaparro-riggers@pfizer.com d.sprengers@erasmusmc.nl tzu-hsuan.huang@pfizer.com., Chaparro-Riggers J; BMD, Pfizer Inc., San Diego, California. javier.chaparro-riggers@pfizer.com d.sprengers@erasmusmc.nl tzu-hsuan.huang@pfizer.com. |
| Source: | Cancer immunology research [Cancer Immunol Res] 2021 Oct; Vol. 9 (10), pp. 1141-1157. Date of Electronic Publication: 2021 Aug 10. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101614637 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2326-6074 (Electronic) Linking ISSN: 23266066 NLM ISO Abbreviation: Cancer Immunol Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 34376502 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: An Engineered IL15 Cytokine Mutein Fused to an Anti-PD1 Improves Intratumoral T-cell Function and Antitumor Immunity. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Xu+Y%22">Xu Y</searchLink>; Cancer Immunology Discovery, Pfizer Inc., San Diego, California.<br /><searchLink fieldCode="AU" term="%22Carrascosa+LC%22">Carrascosa LC</searchLink>; Gastroenterology and Hepatology, Erasmus Medical Center, Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Yeung+YA%22">Yeung YA</searchLink>; BMD, Pfizer Inc., San Diego, California.<br /><searchLink fieldCode="AU" term="%22Chu+ML%22">Chu ML</searchLink>; BMD, Pfizer Inc., San Diego, California.<br /><searchLink fieldCode="AU" term="%22Yang+W%22">Yang W</searchLink>; Computational Biology, Pfizer Inc., San Diego, California.<br /><searchLink fieldCode="AU" term="%22Djuretic+I%22">Djuretic I</searchLink>; Cancer Immunology Discovery, Pfizer Inc., San Diego, California.<br /><searchLink fieldCode="AU" term="%22Pappas+DC%22">Pappas DC</searchLink>; Cancer Immunology Discovery, Pfizer Inc., San Diego, California.<br /><searchLink fieldCode="AU" term="%22Zeytounian+J%22">Zeytounian J</searchLink>; Cancer Immunology Discovery, Pfizer Inc., San Diego, California.<br /><searchLink fieldCode="AU" term="%22Ge+Z%22">Ge Z</searchLink>; Gastroenterology and Hepatology, Erasmus Medical Center, Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22de+Ruiter+V%22">de Ruiter V</searchLink>; Gastroenterology and Hepatology, Erasmus Medical Center, Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Starbeck-Miller+GR%22">Starbeck-Miller GR</searchLink>; Cancer Immunology Discovery, Pfizer Inc., San Diego, California.<br /><searchLink fieldCode="AU" term="%22Patterson+J%22">Patterson J</searchLink>; Cancer Immunology Discovery, Pfizer Inc., San Diego, California.<br /><searchLink fieldCode="AU" term="%22Rigas+D%22">Rigas D</searchLink>; Cancer Immunology Discovery, Pfizer Inc., San Diego, California.<br /><searchLink fieldCode="AU" term="%22Chen+SH%22">Chen SH</searchLink>; Cancer Immunology Discovery, Pfizer Inc., San Diego, California.<br /><searchLink fieldCode="AU" term="%22Kraynov+E%22">Kraynov E</searchLink>; BMD, Pfizer Inc., San Diego, California.<br /><searchLink fieldCode="AU" term="%22Boor+PP%22">Boor PP</searchLink>; Gastroenterology and Hepatology, Erasmus Medical Center, Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Noordam+L%22">Noordam L</searchLink>; Gastroenterology and Hepatology, Erasmus Medical Center, Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Doukas+M%22">Doukas M</searchLink>; Pathology, Erasmus Medical Center, Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Tsao+D%22">Tsao D</searchLink>; Cancer Immunology Discovery, Pfizer Inc., San Diego, California.<br /><searchLink fieldCode="AU" term="%22Ijzermans+JN%22">Ijzermans JN</searchLink>; Surgery, Erasmus Medical Center, Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Guo+J%22">Guo J</searchLink>; BMD, Pfizer Inc., San Diego, California.<br /><searchLink fieldCode="AU" term="%22Grünhagen+DJ%22">Grünhagen DJ</searchLink>; Surgery, Erasmus Medical Center, Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Erdmann+J%22">Erdmann J</searchLink>; Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Verheij+J%22">Verheij J</searchLink>; Pathology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Royen+ME%22">van Royen ME</searchLink>; Pathology, Erasmus Medical Center, Rotterdam, the Netherlands.; Cancer Treatment Screening Facility (CTSF), Erasmus Medical Center, Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Doornebosch+PG%22">Doornebosch PG</searchLink>; Surgery, IJsselland Hospital, Capelle aan den IJssel, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Feldman+R%22">Feldman R</searchLink>; Cancer Immunology Discovery, Pfizer Inc., San Diego, California.<br /><searchLink fieldCode="AU" term="%22Park+T%22">Park T</searchLink>; Cancer Immunology Discovery, Pfizer Inc., San Diego, California.<br /><searchLink fieldCode="AU" term="%22Mahmoudi+S%22">Mahmoudi S</searchLink>; Cancer Immunology Discovery, Pfizer Inc., San Diego, California.<br /><searchLink fieldCode="AU" term="%22Dorywalska+M%22">Dorywalska M</searchLink>; BMD, Pfizer Inc., San Diego, California.<br /><searchLink fieldCode="AU" term="%22Ni+I%22">Ni I</searchLink>; BMD, Pfizer Inc., San Diego, California.<br /><searchLink fieldCode="AU" term="%22Chin+SM%22">Chin SM</searchLink>; BMD, Pfizer Inc., San Diego, California.<br /><searchLink fieldCode="AU" term="%22Mistry+T%22">Mistry T</searchLink>; BMD, Pfizer Inc., San Diego, California.<br /><searchLink fieldCode="AU" term="%22Mosyak+L%22">Mosyak L</searchLink>; BMD, Pfizer Inc., San Diego, California.<br /><searchLink fieldCode="AU" term="%22Lin+L%22">Lin L</searchLink>; BMD, Pfizer Inc., San Diego, California.<br /><searchLink fieldCode="AU" term="%22Ching+KA%22">Ching KA</searchLink>; Computational Biology, Pfizer Inc., San Diego, California.<br /><searchLink fieldCode="AU" term="%22Lindquist+KC%22">Lindquist KC</searchLink>; BMD, Pfizer Inc., San Diego, California.<br /><searchLink fieldCode="AU" term="%22Ji+C%22">Ji C</searchLink>; DSRD, Pfizer Inc., San Diego, California.<br /><searchLink fieldCode="AU" term="%22Londono+LM%22">Londono LM</searchLink>; Cancer Immunology Discovery, Pfizer Inc., San Diego, California.<br /><searchLink fieldCode="AU" term="%22Kuang+B%22">Kuang B</searchLink>; BMD, Pfizer Inc., San Diego, California.<br /><searchLink fieldCode="AU" term="%22Rickert+R%22">Rickert R</searchLink>; Cancer Immunology Discovery, Pfizer Inc., San Diego, California.<br /><searchLink fieldCode="AU" term="%22Kwekkeboom+J%22">Kwekkeboom J</searchLink>; Gastroenterology and Hepatology, Erasmus Medical Center, Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Sprengers+D%22">Sprengers D</searchLink>; Gastroenterology and Hepatology, Erasmus Medical Center, Rotterdam, the Netherlands. javier.chaparro-riggers@pfizer.com d.sprengers@erasmusmc.nl tzu-hsuan.huang@pfizer.com.<br /><searchLink fieldCode="AU" term="%22Huang+TH%22">Huang TH</searchLink>; Cancer Immunology Discovery, Pfizer Inc., San Diego, California. javier.chaparro-riggers@pfizer.com d.sprengers@erasmusmc.nl tzu-hsuan.huang@pfizer.com.<br /><searchLink fieldCode="AU" term="%22Chaparro-Riggers+J%22">Chaparro-Riggers J</searchLink>; BMD, Pfizer Inc., San Diego, California. javier.chaparro-riggers@pfizer.com d.sprengers@erasmusmc.nl tzu-hsuan.huang@pfizer.com. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101614637%22">Cancer immunology research</searchLink> [Cancer Immunol Res] 2021 Oct; Vol. 9 (10), pp. 1141-1157. <i>Date of Electronic Publication: </i>2021 Aug 10. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%22">American Association for Cancer Research </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101614637 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2326-6074 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223266066%22">23266066 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Immunol Res <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34376502 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1158/2326-6066.CIR-21-0058 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1141 Titles: – TitleFull: An Engineered IL15 Cytokine Mutein Fused to an Anti-PD1 Improves Intratumoral T-cell Function and Antitumor Immunity. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Xu Y – PersonEntity: Name: NameFull: Carrascosa LC – PersonEntity: Name: NameFull: Yeung YA – PersonEntity: Name: NameFull: Chu ML – PersonEntity: Name: NameFull: Yang W – PersonEntity: Name: NameFull: Djuretic I – PersonEntity: Name: NameFull: Pappas DC – PersonEntity: Name: NameFull: Zeytounian J – PersonEntity: Name: NameFull: Ge Z – PersonEntity: Name: NameFull: de Ruiter V – PersonEntity: Name: NameFull: Starbeck-Miller GR – PersonEntity: Name: NameFull: Patterson J – PersonEntity: Name: NameFull: Rigas D – PersonEntity: Name: NameFull: Chen SH – PersonEntity: Name: NameFull: Kraynov E – PersonEntity: Name: NameFull: Boor PP – PersonEntity: Name: NameFull: Noordam L – PersonEntity: Name: NameFull: Doukas M – PersonEntity: Name: NameFull: Tsao D – PersonEntity: Name: NameFull: Ijzermans JN – PersonEntity: Name: NameFull: Guo J – PersonEntity: Name: NameFull: Grünhagen DJ – PersonEntity: Name: NameFull: Erdmann J – PersonEntity: Name: NameFull: Verheij J – PersonEntity: Name: NameFull: van Royen ME – PersonEntity: Name: NameFull: Doornebosch PG – PersonEntity: Name: NameFull: Feldman R – PersonEntity: Name: NameFull: Park T – PersonEntity: Name: NameFull: Mahmoudi S – PersonEntity: Name: NameFull: Dorywalska M – PersonEntity: Name: NameFull: Ni I – PersonEntity: Name: NameFull: Chin SM – PersonEntity: Name: NameFull: Mistry T – PersonEntity: Name: NameFull: Mosyak L – PersonEntity: Name: NameFull: Lin L – PersonEntity: Name: NameFull: Ching KA – PersonEntity: Name: NameFull: Lindquist KC – PersonEntity: Name: NameFull: Ji C – PersonEntity: Name: NameFull: Londono LM – PersonEntity: Name: NameFull: Kuang B – PersonEntity: Name: NameFull: Rickert R – PersonEntity: Name: NameFull: Kwekkeboom J – PersonEntity: Name: NameFull: Sprengers D – PersonEntity: Name: NameFull: Huang TH – PersonEntity: Name: NameFull: Chaparro-Riggers J IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 10 Text: 2021 Oct Type: published Y: 2021 Identifiers: – Type: issn-electronic Value: 2326-6074 Numbering: – Type: volume Value: 9 – Type: issue Value: 10 Titles: – TitleFull: Cancer immunology research Type: main |
| ResultId | 1 |